Triclabendazole
Y. Vivian Tsai, Pharm.D.
,
Paul G. Auwaerter, M.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Treatment of
fascioliasis
in patients ≥ 6 years.
[10]
[1]
[11]
[8]
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Alternative treatment of pulmonary paragonimiasis in patients ≥ 6 years.
[11]
[12]
[13]
[14]
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2026 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.